Bilateral Breast Carcinoma
4 clinical trials · Condition
◉ Watch Bilateral Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer (NCT04052555) | National Cancer Institute (NCI) | 2020-09-24 |
| Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer (NCT03012100) | Academic and Community Cancer Research United | 2017-03-31 |
| Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy (NCT00877500) | M.D. Anderson Cancer Center | 2009-03-30 |
Track Bilateral Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.